Search research articles
Contact Us
Filters
Showing results (171-180 of 282) with videos related to
Page
of 29
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 12, 2016
Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis
Julie Fox, Juan M Tiraboschi, Carolina Herrera, et al.
The Journal of Antimicrobial Chemotherapy
|
October 2, 2013
Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients
Fred S Sarfo, Yuan Zhang, Deirdre Egan, et al.
The Journal of Antimicrobial Chemotherapy
|
May 17, 2024
Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testing
Laura J Else, Laura Dickinson, Stacey Edick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 20, 2019
TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy
Sudeep Pushpakom, Ruwanthi Kolamunnage-Dona, Claire Taylor, et al.
The Journal of Antimicrobial Chemotherapy
|
October 19, 2014
Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS
Adeniyi Olagunju, Oluseye O Bolaji, Alieu Amara, et al.
British Journal of Clinical Pharmacology
|
March 6, 2019
Cerebrospinal fluid exposure of cenicriviroc in HIV-positive individuals with cognitive impairment
Jasmini Alagaratnam, Sujan Dilly-Penchala, Elizabeth Challenger, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 24, 2007
A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin
Ruben C Hartkoorn, Saye Khoo, David J Back, et al.
Annals of Internal Medicine
|
February 28, 2022
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions
Catia Marzolini, Daniel R Kuritzkes, Fiona Marra, et al.
AIDS (London, England)
|
September 27, 2014
No pharmacokinetic interaction between raltegravir and amlodipine: importance for co-prescribing in ageing HIV-infected individuals
Gurmit J Singh, Akil Jackson, Antonio D'Avolio, et al.
Journal of Hepatology
|
March 22, 2017
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients
Luca S Belli, Christophe Duvoux, Marina Berenguer, et al.
Page
of 29
Search research articles
Search
Showing results (171-180 of 282) with videos related to
Sort By:
Page
of 29
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 12, 2016
Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis
Julie Fox, Juan M Tiraboschi, Carolina Herrera, et al.
The Journal of Antimicrobial Chemotherapy
|
October 2, 2013
Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients
Fred S Sarfo, Yuan Zhang, Deirdre Egan, et al.
The Journal of Antimicrobial Chemotherapy
|
May 17, 2024
Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testing
Laura J Else, Laura Dickinson, Stacey Edick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 20, 2019
TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy
Sudeep Pushpakom, Ruwanthi Kolamunnage-Dona, Claire Taylor, et al.
The Journal of Antimicrobial Chemotherapy
|
October 19, 2014
Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS
Adeniyi Olagunju, Oluseye O Bolaji, Alieu Amara, et al.
British Journal of Clinical Pharmacology
|
March 6, 2019
Cerebrospinal fluid exposure of cenicriviroc in HIV-positive individuals with cognitive impairment
Jasmini Alagaratnam, Sujan Dilly-Penchala, Elizabeth Challenger, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 24, 2007
A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin
Ruben C Hartkoorn, Saye Khoo, David J Back, et al.
Annals of Internal Medicine
|
February 28, 2022
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions
Catia Marzolini, Daniel R Kuritzkes, Fiona Marra, et al.
AIDS (London, England)
|
September 27, 2014
No pharmacokinetic interaction between raltegravir and amlodipine: importance for co-prescribing in ageing HIV-infected individuals
Gurmit J Singh, Akil Jackson, Antonio D'Avolio, et al.
Journal of Hepatology
|
March 22, 2017
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients
Luca S Belli, Christophe Duvoux, Marina Berenguer, et al.
Page
of 29